Texas is Rolling Out the Welcome Mat for China’s Copper Takeover
China is quietly making a move on one of America’s most critical industrial materials — copper. Texas is helping them do it.
CPA Applauds Expanded Pentagon List of Chinese Military Companies
CPA welcomed the U.S. Department of War expanding its Section 1260H list of Chinese military companies and praised recent efforts by lawmakers, including Senator Rick Scott (R-FL), to draw greater attention to the threat posed by China’s military-civil fusion strategy.
CPA Applauds Executive Order Strengthening Customs Enforcement, Cracking Down on Non-Resident Importers and Weak Bonding
For too long, foreign actors with no real U.S. presence have been able to import into the American market while shielding themselves from the duties, penalties, and laws that domestic producers and legitimate U.S. importers must obey. The order takes aim squarely at that imbalance.
Mike Froman Is Wrong Again: Manufacturing Jobs Are Among America’s Best Jobs
While hosting Ambassador Greer, the former USTR manipulated pay data to claim that services jobs had overtaken manufacturing.
CPA Warns of Critical U.S. Vulnerabilities in Antibiotic Supply Chain, Calls for Action to Protect and Rebuild Domestic and Allied Production
Without secure upstream API and 6-APA production, the United States does not have true antibiotic supply security. With the right policy framework and close coordination with European partners, we can rebuild domestic capacity, strengthen allied production, and secure essential medicines for the long term.
CPA: Solar Trade Case Preliminary Duties Underscore Need for Full Supply Chain Action in Polysilicon 232
The findings reinforce a persistent pattern in global solar trade: when enforcement actions target specific countries, production and shipments shift to new jurisdictions.
CPA Submits Comments to USITC on China’s Permanent Normal Trade Relations
Revoking PNTR for China would move Chinese imports onto an average effective Column 2 tariff rate of 38.9 percent, helping rebalance trade, restore domestic production capacity, and reduce strategic dependence on an increasingly adversarial economic system.
CPA Applauds FDA Proposal to Strengthen U.S. Generic Drug Manufacturing and Supply Chain Integrity
CPA welcomes new proposals from the Food and Drug Administration (FDA) aimed at rebuilding domestic generic drug manufacturing, strengthening oversight of foreign pharmaceutical production, and improving supply chain transparency.
New CPA Report Shows Domestic Manufacturing Market Share Rebounds in 2025 as Tariffs Begin to Reshape U.S. Industry
The report finds that the CPA Domestic Market Share Index (DMSI) – which measures the share of U.S. demand served by domestic producers – rebounded in 2025 as Section 232 tariffs and other industrial policies began to reshape the competitive landscape for American industry.
CPA Applauds Suniva’s Major U.S. Solar Cell Manufacturing Investment
Suniva’s expansion highlights the critical importance of rebuilding the domestic crystalline silicon photovoltaic (PV) supply chain—particularly solar cell manufacturing, one of the most strategically important segments of U.S. energy production.
